Device and method for in vivo photoacoustic diagnosis and photothermal purging of infected blood

1. A method for selectively destroying a plurality of circulating bacterial cells in a vessel of a living organism in vivo, comprising:

injecting or transfusing at least one contrast agent into the vessel, wherein the at least one contrast agent comprises at least one antibody to target the plurality of circulating bacterial cells;

contacting the plurality of circulating bacterial cells with the contrast agent in vivo;

pulsing the vessel with at least one pulse of NIR laser energy at a first wavelength;

receiving, by an ultrasound transducer, at least one photoacoustic pulse;

analyzing the at least one received photoacoustic pulse to indicate a frequency of detection of the plurality of circulating bacterial cells;

triggering a destruction pulse of laser energy delivered at a second wavelength and energy level sufficient to cause destruction of the one or more detected bacterial cells when the frequency of detection is above a threshold level;

monitoring the frequency of detection of a remaining portion of the plurality of circulating bacterial cells through the vessel; and

terminating the destruction pulse of laser energy when the frequency of detection of the remaining portion of the plurality of circulating bacterial cells falls below the threshold level,

wherein the at least one contrast agent is selected from a mixture of gold nanorods with a first maximal absorption wavelength and gold nanorods with a second maximal absorption wavelength, and a silica-coated magnetic nanoparticle, and the at least one antibody is selected from an antibody to protein A receptors of Staphylococcus aureus , an antibody to a lipoprotein, and combinations thereof.

2. The method of claim 1 , wherein the one or more of the plurality of circulating bacterial cells are detected using an in vivo flow cytometry device using laser-excited photoacoustic waves emitted by the one or more of the plurality of circulating bacterial cells.

3. The method of claim 1 , wherein the threshold level of the frequency of detection ranges between about 10 −3 target objects/min and about 10 2 target objects/min.

4. The method of claim 1 , wherein the first wavelength is used with a first contrast agent to detect the one or more of the plurality of circulating bacterial cells and the second wavelength is used with a second contrast agent to destroy the one or more detected bacterial cells.

5. The method of claim 1 , further comprising continuously withdrawing a portion of blood from the vessel out of the living organism to an extracorporeal shunt comprising a circulatory bypass tube, directing the portion of blood through the circulatory bypass tube, and returning the portion of blood back into the vessel of the living organism, wherein the area of interest includes a cross-section situated within the circulatory bypass tube.

6. A method for selectively destroying a plurality of circulating bacterial cells in a vessel of a living organism in vivo, comprising:

injecting or transfusing at least one contrast agent into the vessel, wherein the at least one contrast agent comprises at least one antibody to target the plurality of circulating bacterial cells;

contacting the plurality of circulating bacterial cells with the at least one contrast agent in vivo;

pulsing the vessel with at least one laser pulse at a first wavelength;

receiving, by an ultrasound transducer, at least one photoacoustic pulse;

triggering a pulse of laser energy delivered at a second wavelength and energy level sufficient to cause destruction of one or more of the plurality of circulating bacterial cells;

monitoring a frequency of destruction of the plurality of circulating bacterial cells; and,

terminating when the frequency of destruction of the plurality of circulating bacterial cells falls below a threshold level,

wherein the at least one contrast agent is selected from a mixture of gold nanorods with a first maximal absorption wavelength and gold nanorods with a second maximal absorption wavelength, and a silica-coated magnetic nanoparticle, and the at least one antibody is selected from an antibody to protein A receptors of Staphylococcus aureus , an antibody to a lipoprotein, and combinations thereof.

7. The method of claim 6 , wherein the threshold level of the frequency of destruction ranges between about 10 −3 target objects/min and about 10 2 target objects/min.

8. The method of claim 6 , further comprising continuously withdrawing a portion of blood from the vessel out of the living organism to an extracorporeal shunt comprising a circulatory bypass tube, directing the portion of blood through the circulatory bypass tube, and returning the portion of blood back into the vessel of the living organism, wherein the area of interest includes a cross-section situated within the circulatory bypass tube.

9. The method of claim 1 , wherein the first maximal absorption wavelength is about 690 nm and the second maximal absorption wavelength is about 900 nm.

10. The method of claim 6 , wherein the first maximal absorption wavelength is about 690 nm and the second maximal absorption wavelength is about 900 nm.

11. The method of claim 9 , wherein the mixture of gold nanorods comprises anti-Spa (GNR 900 ) and anti-Lpp)(GNR 690 ).

12. The method of claim 10 , wherein the mixture of gold nanorods comprises anti-Spa (GNR 900 ) and anti-Lpp)(GNR 690 ).

13. The method of claim 1 , wherein the first wavelength is 671 nm and the second wavelength is 880 nm.

14. The method of claim 1 , further comprising a time delay of 10 μs between the laser pulse at the first wavelength and the laser pulse at the second wavelength.

15. The method of claim 6 , wherein the first wavelength is 671 nm and the second wavelength is 880 nm.

16. The method of claim 6 , further comprising a time delay of 10 μs between the laser pulse at the first wavelength and the laser pulse at the second wavelength.